Health & Medicine World stem cells & regenerative medicine congress, london, may 22, 2013

1. This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced Cell Technology Inc”, or “the Company”) salient business characteristics.…

Technology Vision Research Symposium Conference Presentation

1. The use of embryonic stem cells in regenerative medicineRobert Lanza, MDVP Research & Scientific DevelopmentAdvanced Cell Technologyand Adjunct ProfessorWake Forest…